Menopause

Starting estrogen therapy in perimenopause was associated with reduced risks of breast cancer, heart attack, and stroke, study shows.

A new study found that transdermal hormone therapy may lower anxiety and depression risk compared with oral therapy in postmenopausal women.

Menopause remains a taboo topic in many cultures, yet women seek to educate themselves and support each other through shared experiences.

A Wake Forest study finds that provider specialty and training shape how women receive medication treatment for menopause symptoms.

Andrew Kaunitz, MD, shares how older women can explore safe contraceptive options while understanding fertility risks.

Most perimenopausal and menopausal women report digestive symptoms, but few receive diagnosis or adequate care, new UK study finds.

Researchers highlight overlap between menopause and TBI symptoms, calling for hormone-informed tools in brain injury assessment.

A review presented at The Menopause Society 2025 highlights the links between menopause-related brain changes and cognitive function.

A large TriNetX analysis found hormone therapy use in postmenopausal women was linked to a higher incidence of autoimmune diseases.

The Menopause Society’s 2025 meeting heads to Orlando with sessions on longevity, hormones, cognition, and care innovation at midlife and beyond.

Researchers from found that hormone replacement therapy may restore immune function changes linked to menopause.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

Sarah Glynne, MBBS, BSc, and Jayant S. Vaidya, MD, FRCS, PhD, urge clinicians to move beyond blanket bans and support informed, patient-centered care.

Jayant S. Vaidya, MD, FRCS, PhD, and Sarah Glynne, MBBS, BSc, discuss new evidence challenging the blanket ban on HRT use after breast cancer.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

A study found that menopause does not increase disability progression in women with multiple sclerosis

In the 52-week OASIS-3 trial, elinzanetant significantly reduced the frequency and severity of hot flashes and night sweats.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

Findings from the OASIS-3 trial show the nonhormonal drug elinzanetant cut vasomotor symptoms by 73%.

New research shows oral HRT increases cardiovascular risks in women with type 2 diabetes, while transdermal HRT appears to be safer.

A national poll finds most women underestimate diet’s role in reducing menopause symptoms, despite evidence for plant-based diets with soy.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

Experts urge a shift toward symptom-based menopause care, citing the high cost and limited clinical value of routine hormone panel testing.

Vaginal estrogen tablets were not associated with increased risk of recurrent ischemic stroke in postmenopausal women with prior stroke.

Epigenetic aging raises colorectal cancer risk in postmenopausal women, but higher fruit and vegetable intake may help offset this risk.